Robert A. Lenz serves as Executive at Neumora Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Robert A. Lenz has executed 5 insider transactions totaling $869.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 18, 2024 involved selling 10,676 shares valued at $129.1K.
Robert A. Lenz currently holds 328,529 shares of Neumora Therapeutics, Inc. (NMRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert A. Lenz has been a net seller of NMRA stock. They have purchased $0 and sold $869.3K worth of shares.
Robert A. Lenz's most recent insider trade was on Sep 18, 2024, when they sold 10,676 shares at $12.09 per share.
Get notified when new Form 4 filings are submitted
| $11.81 |
| Planned |
| Sep 12, 2024 | NMRA | $376.6K | Sale | 32,948 | $11.43 | Planned |
| Feb 14, 2024 | NMRA | $0 | Award | 50,000 | $N/A | Discretionary |
| Sep 14, 2023 | NMRA | $0 | Award | 352,941 | $N/A | Discretionary |